News Focus
News Focus
icon url

arvitar

01/13/17 10:54 PM

#129099 RE: BonelessCat #129091

something that took about 10 of those 12 years to become evident.



Lord only knows what has "become evident" over the most recent of those 12 years. Or what will "become evident" over the next 12 years.

It was just a year ago when Seymour was saying this:

"As noted by NNVC in the Jan 2016 Biotech Showcase concerning the lead Herpescide candidate:

May - July: Univ testing to select optimum candidate complete
August - Sept: TOX prep complete
Nov - Dec: TOX package complete
Dec - Feb: Human trials begin"


icon url

JG36

01/14/17 2:16 AM

#129102 RE: BonelessCat #129091

Maybe NNVC should just make 10 copies of their 200 mg production equipment and get on with 2 kg production that way.
icon url

Rawnoc

01/15/17 9:40 AM

#129121 RE: BonelessCat #129091

What bullshit -- the consistentcy problem is something that has plagued many nanomed companies so Seymour should not have been surprised. He chose to downplay it and instead keep everybody focused on batch size, new monthly flavors, and blaming BASI.

For years it was that they have to make so much of the drug because it's so safe. Nonsense. The main issue was and still that they can't make any useful batches because without consistency they're all worthless.